questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de transport
Protéines AAA
Protéines AAA : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines AAA : Questions médicales les plus fréquentes",
"headline": "Protéines AAA : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines AAA : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines AAA"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de transport",
"url": "https://questionsmedicales.fr/mesh/D002352",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de transport",
"code": {
"@type": "MedicalCode",
"code": "D002352",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATPases associated with diverse cellular activities",
"alternateName": "ATPases Associated with Diverse Cellular Activities",
"url": "https://questionsmedicales.fr/mesh/D000074183",
"about": {
"@type": "MedicalCondition",
"name": "ATPases associated with diverse cellular activities",
"code": {
"@type": "MedicalCode",
"code": "D000074183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent proteases",
"alternateName": "ATP-Dependent Proteases",
"url": "https://questionsmedicales.fr/mesh/D049069",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent proteases",
"code": {
"@type": "MedicalCode",
"code": "D049069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-Ethylmaleimide-sensitive factors",
"alternateName": "N-Ethylmaleimide-Sensitive Proteins",
"url": "https://questionsmedicales.fr/mesh/D052066",
"about": {
"@type": "MedicalCondition",
"name": "N-Ethylmaleimide-sensitive factors",
"code": {
"@type": "MedicalCode",
"code": "D052066",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.375"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines AAA",
"alternateName": "AAA Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000074582",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tarun M Kapoor",
"url": "https://questionsmedicales.fr/author/Tarun%20M%20Kapoor",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA. kapoor@rockefeller.edu."
}
},
{
"@type": "Person",
"name": "Tommaso Cupido",
"url": "https://questionsmedicales.fr/author/Tommaso%20Cupido",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Rudolf Pisa",
"url": "https://questionsmedicales.fr/author/Rudolf%20Pisa",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Chemistry and Cell Biology, The Rockefeller University, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "James Shorter",
"url": "https://questionsmedicales.fr/author/James%20Shorter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A."
}
},
{
"@type": "Person",
"name": "Robert T Sauer",
"url": "https://questionsmedicales.fr/author/Robert%20T%20Sauer",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The association between C-peptide and atrial cardiomyopathy in nondiabetic adults: results from NHANES III.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36928669",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00380-023-02259-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Copper(II) Affects the Biochemical Behavior of Proinsulin C-peptide by Forming Ternary Complexes with Serum Albumin.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37486968",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/jacs.3c04599"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship of Glucose, C-peptide, Leptin, and BDNF in Maternal and Umbilical Vein Blood in Type-1 Diabetes.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36771307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu15030600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of C-peptide level with peripheral neuropathy in type 2 diabetes: An observational cross-sectional preliminary study.",
"datePublished": "2023-02-11",
"url": "https://questionsmedicales.fr/article/36805166",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.dsx.2023.102725"
}
},
{
"@type": "ScholarlyArticle",
"name": "Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations.",
"datePublished": "2024-08-01",
"url": "https://questionsmedicales.fr/article/39149119",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2024.1419329"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de transport",
"item": "https://questionsmedicales.fr/mesh/D002352"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines AAA",
"item": "https://questionsmedicales.fr/mesh/D000074582"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines AAA - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines AAA",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines AAA",
"description": "Comment diagnostiquer une dysfonction des protéines AAA ?\nQuels tests sont utilisés pour évaluer les protéines AAA ?\nLes biopsies sont-elles utiles pour les protéines AAA ?\nQuels marqueurs biologiques sont associés aux protéines AAA ?\nLes imageries médicales aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines AAA",
"description": "Quels symptômes indiquent une anomalie des protéines AAA ?\nLes troubles cognitifs sont-ils liés aux protéines AAA ?\nY a-t-il des symptômes cutanés associés ?\nLes douleurs musculaires sont-elles fréquentes ?\nLes symptômes varient-ils selon les types de protéines AAA ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines AAA",
"description": "Peut-on prévenir les dysfonctionnements des protéines AAA ?\nLes dépistages réguliers sont-ils utiles ?\nL'éducation génétique est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des protéines ?\nLe stress a-t-il un impact sur les protéines AAA ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines AAA",
"description": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?\nLa thérapie génique est-elle efficace ?\nDes médicaments spécifiques sont-ils disponibles ?\nLes approches nutritionnelles aident-elles ?\nLa physiothérapie est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines AAA",
"description": "Quelles complications peuvent survenir avec les protéines AAA ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il des risques de cancer associés ?\nLes troubles métaboliques sont-ils possibles ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines AAA",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?\nL'hérédité joue-t-elle un rôle ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles affecter les protéines AAA ?\nLe vieillissement est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D000074582?mesh_terms=C-Peptide&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des protéines AAA ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses protéomiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les protéines AAA ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction cellulaire et des dosages d'ATPase peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour les protéines AAA ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à évaluer l'expression des protéines AAA dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux protéines AAA ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme Hsp70 peuvent être utilisés pour évaluer l'activité des protéines AAA."
}
},
{
"@type": "Question",
"name": "Les imageries médicales aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut montrer des anomalies cellulaires, mais n'est pas spécifique aux protéines AAA."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des protéines AAA ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes incluent la faiblesse musculaire, la fatigue et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils liés aux protéines AAA ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent entraîner des troubles cognitifs et de la mémoire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies liées aux protéines AAA peuvent provoquer des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les douleurs musculaires sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires peuvent survenir en raison de dysfonctionnements des protéines."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les types de protéines AAA ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de protéine AAA impliquée et la pathologie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des protéines AAA ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages peuvent aider à identifier précocement les anomalies génétiques."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les maladies héréditaires peut aider à la prévention."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la santé des protéines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire et protéique."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les protéines AAA ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction cellulaire et les protéines."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les dysfonctionnements des protéines AAA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies géniques et des médicaments ciblant les voies cellulaires."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique montre des résultats prometteurs dans certaines pathologies liées."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques sont-ils disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de l'ATPase sont en cours d'étude pour traiter les dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Les approches nutritionnelles aident-elles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une nutrition adéquate peut soutenir la fonction cellulaire, mais n'est pas un traitement direct."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut aider à gérer les symptômes musculaires et améliorer la fonction."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les protéines AAA ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies neurodégénératives et des troubles musculaires."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines dysfonctionnements des protéines AAA peuvent augmenter le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans les protéines AAA peuvent être liées à certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent entraîner des troubles métaboliques variés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements des protéines AAA ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques, l'âge et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines mutations génétiques héréditaires augmentent le risque de dysfonction."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les protéines AAA ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber la fonction des protéines AAA."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des protéines et augmenter les risques."
}
}
]
}
]
}
Serum C-peptide exhibits various biological activities. The relationship between C-peptide and atrial cardiomyopathy remains unknown. We aimed to investigate the association between C-peptide level an...
Peptide hormones are essential signaling molecules with therapeutic importance. Identifying regulatory factors that drive their activity gives important insight into their mode of action and clinical ...
The study aimed to determine the relationship between glucose, C-peptide, brain-derived neurotrophic factor (BDNF), and leptin between mother and fetus and neonatal weight....
In the prospective observational cohort study, we included 66 women with type-1 diabetes mellitus (T1DM). According to the z-score for neonatal weight, patients were divided into healthy-weight neonat...
A strong correlation was confirmed between maternal and umbilical vein glucose concentration and maternal glucose and C-peptide in umbilical vein blood. A negative correlation was found between the co...
Maternal glucose concentrations affect the fetus's glucose, C-peptide, and BDNF concentrations. Leptin levels increase in maternal blood due to increased body mass index, and in the neonate, fat body ...
Peripheral neuropathy is the most common microvascular complication of diabetes mellitus. In subjects with type 1 diabetes (T1D) relationship of C-peptide levels and neuropathy has been observed in se...
One hundred patients of T2D were included in this study. Clinical and laboratory parameter was assessed for all participants. The C-peptide level was measured by fluorometric enzyme immunoassay method...
Total 100 patients completed the study. Mean age of subjects was 60.03 years and male: female ratio was 1.17. Peripheral neuropathy was detected in 47% of subjects evaluated. Subjects were further div...
Serum C-peptide concentrations are associated with peripheral neuropathy in T2DM patients, independent of the degree of glycemic control....
The functional changes in alpha cells in patients with type 1 diabetes (T1D) with different residual beta cell functions remain poorly elucidated. The study aimed to investigate the relationship betwe...
The study enrolled 43 adult patients with T1D and 24 healthy control subjects. Patients with T1D who underwent BMTT were divided into two groups based on peak C-peptide levels: C peptide low (CPL; C-p...
Compared to healthy individuals, fasting plasma glucagon was lower and postprandial plasma glucagon level was increased in patients with T1D. Glucagon levels after BMTT between the CPL and CPH group s...
Stimulated C-peptide levels affect the paradoxical increase in postprandial glucagon secretion in patients with T1D, especially late glucagon response. The exaggerated postprandial glucagon secretion ...
The conclusion between Connecting peptide (C-peptide) and diabetic chronic complication was controversial. The purpose of this study is to explore the possible association between average C-peptide wi...
This is a retro-prospective study. 622 patients with type 2 diabetes were included. DR was evaluated using non-mydriatic fundus photography and DR progression was defined as any deterioration of eithe...
DR was present in 162 (26.0%) patients at baseline, and 26.4% of patients were found progression of DR at follow-up. Patients with progression of DR had lower average levels of 30-minute postprandial ...
Our results suggest that the Average 30-minute post-prandial C-peptide and increment were negatively correlated with DR progression, which further demonstrates the importance to preserve β-cell residu...
Not applicable....
Elevated C-peptide has been suggested as a risk factor for coronary artery disease (CAD). Elevated urinary C-peptide to creatinine ratio (UCPCR) as an alternative measurement is shown to be related to...
279 patients previously diagnosed with T1DM included and categorized into two groups of CAD (n = 84) and without-CAD (n = 195). Furthermore, each group was divided into obese (body mass index (BMI) ≥ ...
Median level of UCPCR was higher in CAD group compared to non-CAD group (0.07 vs. 0.04, respectively). Also, the well-acknowledged risk factors including being active smoker, hypertension, duration of...
UCPCR is associated with clinical CAD, independent of CAD classic risk factors, glycaemic control, insulin resistance and BMI in type 1 DM patients....
This study aims to investigate the effect of single urine C peptide/creatinine (UCPCR) in assessing the islet β Cell function of type 2 diabetes mellitus (T2DM) patients with different renal function....
A total of 85 T2DM patients were recruited in this study, all the patients were assigned to one group with estimated glomerular filtration rate (eGFR)≤60 ml·min...
When compared with group eGFR ≤60 ml·min...
UCPCR can be used to evaluate islets β Cell function in T2DM patients with different renal function status....
To determine the prognostic value of C-peptide in long-term nonalcoholic fatty liver disease (NAFLD) mortality....
A total of 4670 participants with NAFLD were enrolled in this study. Multivariable Cox regression models evaluated the links between C-peptide levels and all-cause and cardiovascular disease (CVD) mor...
After a mean follow‑up period of 20 years, 1714 deaths from all causes were recorded. In an adjusted Cox regression analysis, using the low C-peptide group as the reference (quartile 1), higher C-pept...
In the US NAFLD population defined by ultrasound, a U-shaped association was detected between baseline serum C-peptide level and all-cause mortality....
Metabolic syndrome (MetS) is a condition defined by a cluster of symptoms, including excessive adipose tissue, impaired glucose homeostasis, dyslipidemia, and high blood pressure (BP). We aimed to eva...